---
layout: default
title: Geongyu Lee | AI Researcher
---

<!-- Global Navigation Bar -->
<div style="
  width:100%;
  background:#ffffffdd;
  backdrop-filter:blur(8px);
  border-bottom:1px solid #e5e5e5;
  padding:12px 22px;
  display:flex;
  justify-content:space-between;
  align-items:center;
  position:sticky;
  top:0;
  z-index:1000;
">
  <div style="font-weight:700; font-size:16px;">
    ğŸŒ Geongyu Lee
  </div>
  <div style="display:flex; gap:18px; font-weight:600;">
    <a href="/" style="text-decoration:none; color:#666;">EN</a>
    <a href="/ko/" style="text-decoration:none; color:#666;">KR</a>
    <a href="/ja/" style="text-decoration:none; color:#666;">JP</a>
    <a href="/zh/" style="text-decoration:none; color:#0366d6;">CN</a>
  </div>
</div>

# Geongyu Lee  
AI Researcher Â· Computational Pathology Â· Multi-Omics Modeling  

---

# å°ˆæ¥­æ¦‚è¦  
å°ˆæ³¨æ–¼ **è¨ˆç®—ç—…ç†å­¸ï¼ˆComputational Pathologyï¼‰** èˆ‡ **å¤šçµ„å­¸å»ºæ¨¡ï¼ˆMulti-Omics Modelingï¼‰** ä¹‹ AI ç ”ç©¶è€…ã€‚  
ä»¥æ·±åº¦å­¸ç¿’æ–¹å¼æ•´åˆ H&E ç—…ç†å½±åƒèˆ‡è›‹ç™½è³ªé«”ï¼ˆproteomicsï¼‰è³‡æ–™ï¼Œé–‹ç™¼ multi-omics foundation modelï¼Œ  
ä¸¦è‡´åŠ›æ–¼ cell perturbation é æ¸¬èˆ‡è½‰è­¯ç”Ÿç‰©è³‡è¨Šå­¸ï¼ˆtranslational bioinformaticsï¼‰ä¹‹ç ”ç©¶ã€‚

ç ”ç©¶ç›®æ¨™ç‚ºå»ºç«‹ **å…·è‡¨åºŠå¯ç”¨æ€§èˆ‡è§£é‡‹æ€§ï¼ˆinterpretabilityï¼‰** çš„ç”Ÿé†« AI æ¨¡å‹ï¼Œ  
æ‡‰ç”¨æ–¼è…«ç˜¤å­¸ã€ä»¥è›‹ç™½è³ªé«”ç‚ºåŸºç¤çš„ç²¾æº–é†«ç™‚ï¼ˆprecision medicineï¼‰åŠè—¥ç‰©åæ‡‰é æ¸¬ã€‚

---

# å·¥ä½œç¶“æ­·

## RadiSen Co., Ltd.ï¼ˆç”± OMIXAI æ”¶è³¼ï¼‰â€” AI Researcher  
**2025.02 â€“ è‡³ä»Š**  
- ä¸»å°æ•´åˆ proteomics èˆ‡ç—…ç†å½±åƒçš„ multi-omics foundation model ç ”ç©¶èˆ‡é–‹ç™¼ã€‚  
- å»ºæ§‹ self-supervised proteomics representation pipelineï¼Œä¸¦å¯¦ä½œ LoRA å¾®èª¿ã€‚  
- åƒèˆ‡ Virtual Cell Challengeï¼ˆARC Instituteï¼‰ï¼Œé–‹ç™¼ pluripotent stem-cell CRISPR knockdown é æ¸¬æ¨¡å‹ã€‚  
- æ”¯æ´ TNBCï¼ˆä¸‰é™°æ€§ä¹³ç™Œï¼‰ä¹‹ digital pathology éƒ¨ç½²èˆ‡è‡¨åºŠæµç¨‹æ•´åˆã€‚  

---

## Deep Bio Inc. â€” AI Researcher  
**2021.03 â€“ 2025.01**  
- å»ºç«‹ç”¨æ–¼æ—©æœŸä¹³ç™Œå¾©ç™¼é¢¨éšªé æ¸¬çš„ WSIï¼ˆWhole Slide Imageï¼‰åˆ†ææµç¨‹ã€‚  
- ä¸»å°åˆ©ç”¨ H&E å½±åƒèˆ‡è‡¨åºŠè³‡æ–™ä¹‹ cross-modal prostate metastasis detection æ·±åº¦å­¸ç¿’æ¨¡å‹é–‹ç™¼ã€‚  
- é–‹ç™¼çµåˆå½¢æ…‹ç‰¹å¾µèˆ‡åˆ†å­ descriptor çš„ ADME/Tox é æ¸¬æ¡†æ¶ã€‚  
- å”åŠ© digital pathology AI ä¹‹ KFDA æ³•è¦é©—è­‰èˆ‡æäº¤æ–‡ä»¶è£½ä½œã€‚  

---

# æ•™è‚²èƒŒæ™¯

## Seoul National University of Science and Technologyï¼ˆSeoulTechï¼‰  
**è³‡æ–™ç§‘å­¸ ç¢©å£«ï¼ˆ2019â€“2021ï¼‰**  
- æŒ‡å°æ•™æˆï¼š*Prof. Sangheum Hwang*  
- ç¢©å£«è«–æ–‡ï¼š**åˆ©ç”¨ Contrastive Loss æå‡å½±åƒåˆ†å‰²æ¨¡å‹æ•ˆèƒ½ä¹‹ç ”ç©¶**

## Daejeon University  
**è³‡è¨Šå®‰å…¨ å­¸å£«ï¼ˆ2012â€“2019ï¼‰**

---

# ç²¾é¸è«–æ–‡

- **Assessing the risk of recurrence in early-stage breast cancer through H&E-stained whole slide images.**  
  *Scientific Reports (Nature Publishing Group), 2025.*

- **AI-driven Digital Pathology in Urological Cancers: Current Trends and Future Directions.**  
  *Pattern Recognition in Life Sciences / Prostate International, 2025.*

- **MurSS: A Multi-Resolution Selective Segmentation Model for Breast Cancer.**  
  *Bioengineering, 2024.*

- **Supervised Contrastive Embedding for Medical Image Segmentation.**  
  *IEEE Access, 2022.*

---

# Preprints èˆ‡æœƒè­°æ‘˜è¦

- **G2L: From Giga-Scale to Cancer-Specific Pathology Foundation Models via Knowledge Distillation.**  
  *arXiv:2510.11176, 2025.*

- **KPI Challenge 2024: Advancing Glomerular Segmentation from Patch-to-Slide-Level.**  
  *arXiv:2502.07288, 2025.*

- **Predicting Protein Receptor Status from H&E-stained Images in Breast Cancer.**  
  *AACR, 2023.*

- **Automatic Histological Grading of Breast Cancer Resection Tissue.**  
  *USCAP, 2022.*

---

# æ¦®è­½èˆ‡çé …
- **ç¬¬äºŒå â€” ç³¸çƒé«”åˆ†å‰²ï¼ˆWhole-Slide Levelï¼‰**, KPI Challenge 2024  
- **ç¬¬ä¸ƒå â€” æˆ¿åƒ¹é æ¸¬**, Dacon Ã— Zigbangï¼ˆ2018ï¼‰

---

# æŠ€è¡“èƒ½åŠ›

### ç¨‹å¼èªè¨€  
Python / R / JavaScript / Bash  

### æ¡†æ¶  
PyTorch / FastAPI / scikit-learn / Transformers  

### å·¥å…·  
Docker / Git / Linux / VS Code  

### å°ˆæ¥­é ˜åŸŸ  
Deep Learning / Computational Pathology / Multi-Omics Integration / Protein Modeling  

---

# ç ”ç©¶èˆˆè¶£  
Computational Pathology Â· Multi-Omics Modeling Â· Proteomics Integration  
Biomedical Foundation Models Â· Interpretability Â· Cell Perturbation Prediction
